Cuproptosis depicts tumor microenvironment phenotypes and predicts precision immunotherapy and prognosis in bladder carcinoma.

Front Immunol · 2022 · PMC9540537 · PMID 36211344

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an obvious trendno p-value reported

Although without statistic difference, patients in the low cuproptosis signature group showed an obvious trend of higher response rates to immunotherapy in GSE135222 , GSE100797 and PMID26359337 cohorts ( Figures 6B–D ).

also in 1,006 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.